No problem at all, CTDH owns a number of IPs relatede to CD. I beleieve including the proses to make the derivative of CD needed for the drug.
Check out there updated CTDH info on CNN Money:
CTD Holdings, Inc. was organized as a Florida corporation on August 9, 1990, with operations beginning in July 1992. The Company is engaged in the marketing and sale of cyclodextrins and related products to food, pharmaceutical and other industries. The Company also provides consulting services in the area of commercialization of CD applications. Cyclodextrins are molecules that bring together oil and water and have potential applications anywhere oil and water must be used together. The Company's CD products include Trappsol(r), Aquaplex(r), and AP(tm)-Flavor product lines. The Trappsol product line consists of approximately 200 different varieties of CDs and the Aquaplex product line includes more than 60 different complexes of active ingredients with various CDs. In addition to these product lines, the Company introduced Garlessence(r) in the fourth quarter of 1995. Garlessence is the first ingestible product containing CDs to be marketed in the U.S. The Company also provides consulting services, research coordination, and the use of CD Infobase(tm), a comprehensive database of CD related information. The Company has protected its service and trade marks by registering them with the U.S. Patent and Trademark office. The trademarks have been approved and are in use: Trappsol(r), and Aquaplex(r). The Company has established a business relationship with one of the experts in this field-Cyclolab in Hungary - and has utilized the services and expertise of this laboratory. Under the Federal Food, Drug and Cosmetic Act, the Food and Drug Administration is given authority to regulate the development, production, distribution, labeling and promotion of food and drugs.
News 
Market Data 
Discover 
